Health TrialsbyHealthPanel

Predictors of Clinical Course and Treatment Response in DBT Programmes

ConditionsSelf HarmBorderline Personality Disorder
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age12-70
SponsorOslo University Hospital

About this trial

The project is a collaboration between The National Centre for Suicide Research and Prevention (NSSF) and clinical units with Dialectical Behaviour Therapy (DBT) programmes. A methodological and technological platform has been established that enables clinicians to deliver high quality treatments over extended periods of time, to evaluate their own performance and productivity and to report it in a uniform and systematic way that will enable comparison across clinical settings and programmes. The collected data constitute the basis for conducting the clinical study with the overall aim to study predictors of the clinical course and treatment response in patients admitted to DBT programmes in Norway.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

History of repeated deliberate self harm

Satisfies criteria of Diagnostic and Statistical Manual (DSM-IV) Borderline Personality Disorder as measured by Structured Clinical Interview for the DSM (SCID-II) in addition to the self-destructive criterion.

Disqualifiers

Psychotic disorders

Anorexia Nervosa

Substance dependence disorder

Mental retardation (IQ less than 70)

Trial design

Design model

Single group

Treatments tested in this trial

  • Dialectical Behaviour Therapy adapted for adolescents (DBT-A)

    Behavioral

    DBT developed by Marsha Linehan (Linehan 1993a; 1993b) and adapted for adolescents (DBT-A) by Miller, Rathus \& Linehan, 2007 consisting of 20 weeks of weekly individual therapy (60 minutes), multifamily skills training (120 minutes), family therapy sessions as needed and telephone coaching outside therapy sessions.

  • Dialectical Behaviour Therapy - Standard version (DBT)

    Behavioral

    DBT developed by Marsha Linehan (Linehan 1993a, 1993 b) consisting of 1 weekly session of individual therapy (60 minutes), 1 weekly session of skills training (120 minutes), and telephone coaching with individual therapists outside therapy sessions as needed.

Treatment groups

250 Participants
are divided into 1 treatment group
Group A: Dialectical Behaviour TherapyExperimental treatment 2 interventions

Trial outcomes

Primary outcomes

1

Self-harm behaviour

Number of self-harm episodes (split on suicide attempts and non-suicidal self-harm)

Time frame
4 weeks
2

Suicidal Ideation (adolescents)

Suicidal Ideation Questionnaire (SIQ-Jr). Min=0, Max=90. Higher scores indicate worse outcome

Time frame
2 weeks
3

Depressive symptoms

MADRS (Montgomery Asberg Depression Rating Scale).Min=0, Max=60. Higher scores indicate worse outcome

Time frame
1 week
4

Suicidal Ideation (adults)

Beck Scale for Suicidal Ideation (BSS). MIn=0, Max=38. Higher scores indicate worse outcome

Time frame
4 weeks

Secondary outcomes

1

Borderline Symptoms

Borderline Symptom List (BSL-23). Min=0, Max=92. Higher scores indicate more symptoms.

Time frame
1 week
2

Hopelessness

Beck Hopelessness Scale (BHS). Min=0, Max=20. Higher scores indicate more hopelessness.

Time frame
1 week

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Oslo University Hospital

Lead sponsor

Vestre Viken Hospital Trust

Collaborator

St. Olavs Hospital

Collaborator

Sykehuset Ostfold

Collaborator

University of Oslo

Collaborator

Nordlandssykehuset HF

Collaborator

Source ClinicalTrials.gov
Apply now